Skip to main content
Poly Medicure Ltd logo

Poly Medicure Ltd — Investor Relations & Filings

Ticker · POLYMED ISIN · INE205C01021 LEI · 335800XM9YRKFWFVXO61 BSE.NS Manufacturing
Open in API
Filings indexed 1,051 across all filing types
Latest filing 2024-11-13 Regulatory Filings
Country IN India
Listing BSE.NS POLYMED

About Poly Medicure Ltd

https://www.polymedicure.com

Poly Medicure Ltd, known as Polymed, is a global medical device company specializing in the design, development, and manufacture of high-quality medical consumables and equipment. The company offers a comprehensive portfolio of over 160 products across various clinical segments, including infusion therapy, oncology, anesthesia, urology, gastroenterology, blood management, and dialysis. Key offerings include IV cannulas, central venous catheters, blood collection systems, and respiratory care devices. With a strong emphasis on research and development, the company operates multiple state-of-the-art manufacturing facilities and maintains international quality certifications. Polymed serves a diverse global market, providing cost-effective and innovative healthcare solutions to hospitals and medical professionals worldwide.

Recent filings

Filing Released Lang Actions
Statement of deviation(s) and variation(s), if any, of utilization of proceeds received from qualified institutions placement (QIP) under Regulation 32 of SEBI(Listing Obligations and Disclosure ....
Regulatory Filings
2024-11-13 English
Monitoring Agency Report got the quarter ended 30th September, 2024 - QIP
Regulatory Filings
2024-11-13 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings
2024-11-13 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended September 30, 2024' related to the Qualified Institutional Placement (QIP) of Poly Medicure Limited. It references SEBI ICDR Regulations and details the utilization of proceeds from a capital raising event (QIP). The report includes detailed tables on the use of funds, progress on objectives, and deployment of unutilized proceeds. It is issued by CRISIL Ratings Limited as the Monitoring Agency, which is a regulatory requirement for monitoring the use of capital raised through QIP. The document is not a full financial report like an Annual or Interim Report, nor is it a simple announcement or certification. It is a specialized report monitoring capital utilization related to financing activities. Therefore, the most appropriate classification is 'Capital/Financing Update (CAP)'. The document length (15,000 characters) and detailed content support this classification with high confidence.
2024-11-13 English
The Company has informed the exchange about the Earning call transcript
Regulatory Filings
2024-11-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of the Poly Medicure Limited Q2 FY25 Earnings Conference Call held on October 29, 2024. It includes detailed discussions by the management about quarterly financial results, revenue growth, margins, segment performance, capital expenditure, and future outlook. The presence of a moderator, management team members, and a Q&A format typical of earnings calls is evident. The document contains substantive financial data and analysis for the quarter and half-year period, consistent with an earnings call transcript rather than a brief earnings release or other report types. Therefore, the document fits the category of a Call Transcript (CT).
2024-11-06 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.